Health
Inhaled steroid ciclesonide suppresses SARS-CoV-2 replication in vitro – News-Medical.Net
A new paper by researchers at Japan’s National Institute of Infectious Diseases and published on the preprint server bioRxiv in August 2020 reports the in vitro suppression of coronavirus (CoV) replication by an inhaled corticosteroid (ICS) ciclesonide.
With the COVID-19 pandemic, the world has suffered hundreds of thousands of deaths and tens of millions of cases. In order to contain this outbreak, new and already approved drugs are being tested. A new paper by researchers at Japan’s National Institute of Infectious Diseases and published on the preprint server bioRxiv* in August 2020 reports the in vitro suppression of coronavirus (CoV) replication by an inhaled corticosteroid (ICS) ciclesonide.
Steroids have been repurposed for the treatmen…
-
Noosa News22 hours agoEnsure voices are heard – Proctor
-
Noosa News24 hours agoCity of Moreton Bay claims homeless people consented to having camps thrown away
-
Business23 hours agoASX ETFs to target amidst an ageing population
-
Noosa News17 hours agoMajor crash on Gateway Motorway snarls morning commute